Skip to main content

Affy to Open Unit in Japan; Amersham to Cease GeneChip Support Jan. 1

NEW YORK, Sept. 3 - Affymetrix yesterday said it will open a wholly owned subsidiary in Japan to streamline sales, marketing, and support for its GeneChip arrays in that market.


The office, which will open in Tokyo on Jan. 1, will formally take responsibility from Amersham Biosciences, which has been Affy's commission agent in Japan, Affy said.


Click here fore more information.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.